Search Results
442 items found for "LPA receptor"
- Verily links up with Sosei Heptares for GPCR drug discovery
January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers
- Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
as co-founder "Jan 27, 2022 07:00am Septerna wants to spark a second golden age in G-protein-coupled receptor
- 📰 GPCR Weekly News, October 23 to 29, 2023
regulates S1PR1 trafficking and the morphology, cell cycle and survival of PC12 cells GLP-1 and GIP receptors mobilization when combined with propranolol Discovery of 3-Phenyl Indazole-Based Novel Chemokine-like Receptor
- Emerging approaches for decoding neuropeptide transmission
post-translational processing, release from dense core vesicles, and ability to activate G-protein-coupled receptors
- Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
TRV045 is the Company’s novel S1P1 receptor modulator being developed as a potential treatment for diabetic
- GPCR Therapeutics Expands Scientific Advisory Board
biopharmaceutical company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors
- Domain Therapeutics Raises $42m Series A Financing
company specializing in the research and development of innovative drugs targeting G Protein-Coupled Receptors
- High hedgehog signaling is transduced by a multikinase-dependent switch controlling the...
switch controlling the apico-basal distribution of the GPCR smoothened "The oncogenic G-protein-coupled receptor
- Label-free LC-MS based assay to characterize small molecule compound binding to cells
In one example, to study a G protein coupled receptor (GPCR), we used one antagonist as probe and multiple
- Addex Therapeutics Completes Patient Enrollment For Dipraglurant Blepharospasm Phase 2 Clinical ...
Dipraglurant selectively targets the metabotropic glutamate receptor subtype 5 (mGlu5) through allosteric
- Search for safer pain relief advances with new engineered compounds
pain-relieving compounds that, like morphine and other drugs, provide relief via activation of opioid receptors
- Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
biopharmaceutical company specializing in the discovery and development of new drugs targeting G Protein-Coupled Receptors
- Addex Expands Pipeline With Selective M4 Positive Allosteric Modulator Program For The Treatment ...
drug discovery and development, announced today that it has moved a selective and potent M4 muscarinic receptor
- Cholesterol occupies the lipid translocation pathway to block phospholipid scrambling by a GPCR
September 2022 "Class A (rhodopsin-like) G protein-coupled receptors (GPCRs) are constitutive phospholipid
- C3aR plays both sides in regulating resistance to bacterial infections
results in the production of bioactive C3a, a product of C3 cleavage, which interacts with membrane-bound receptor
- 📰 GPCR Weekly News, October 16 to 22, 2023
Signaling β-Arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor distinct inflammatory responses State-dependent dynamics of extramembrane domains in the β2 -adrenergic receptor
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
The targets, including G protein-coupled receptors (GPCRs), intracellular protein complexes and solute
- California gold rush for Sosei Heptares
The vision is to develop novel muscarinic receptor agonists for schizophrenia and other neuropsychiatric
- The Gluopsins: Opsins without the Retinal Binding Lysine
They are G-protein-coupled receptors and bind as ligand retinal, which is bound covalently to a lysine
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled Receptors
- VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron
uses conformationally selective VHH antibodies – ConfoBodies® – to stabilize GPCRs (G protein-coupled receptors
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
pleasure to announce the fourth hybrid symposium on regulatory autoantibodies targeting G-protein-coupled receptors
- The Adhesion GPCR VLGR1/ADGRV1 Regulates the Ca2+ Homeostasis at Mitochondria-Associated ER Membrane
October 2022 "The very large G protein-coupled receptor (VLGR1, ADGRV1) is the largest member of the
- Drug Discovery Picks Up the Pace, Stays on Target
screening, drug efficacy analyses, and toxicity studies; technologies that stabilize G protein–coupled receptors
- GPCR Signaling and mTORC1 Regulation
will discuss the regulation of mTORC1 by upstream stimuli, with a specific focus on G-protein coupled receptor
- Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
June 2022 "G protein-coupled receptors (GPCRs) represent a major therapeutic target class as they play
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
The result suggested that, in contrast to other proton-sensitive channels and receptors, GPR68 did not Molecular basis of proton-sensing by G protein-coupled receptors.
- Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European ...
authorization for the Company’s TAVNEOS (avacopan), an orally administered selective complement 5a receptor